What does this research mean for the field?

Disordered hematopoiesis, driven by metabolic and inflammatory abnormalities that increase the production and activation of monocytes, neutrophils, and platelets, contributes to atherogenesis and athero-thrombosis, highlighting it as a potential therapeutic target. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

February 10, 2016European Heart JournalOpen Access

Disordered haematopoiesis and athero-thrombosis

View Full Paper

Ask AI

Bookmark

Design

Review

Authors

AMAndrew MurphyHarvard University ATAlan R. TallGeneral / Preventive / Lipids

Discussion

Member takes

Implication

May inform trials of hematopoiesis-targeted therapies in atherosclerosis; leaves open clinical adoption pending randomized data.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Murphy et al. (2016) studied this question.

synapsesocial.com/papers/6a1b84e26bdb5bd52d1ceaeb https://doi.org/10.1093/eurheartj/ehv718

View Full Paper

Ask AI

Bookmark

Disordered haematopoiesis and athero-thrombosis

Discussion

Member takes

Implication

Key Points

Cite This Study

Disordered haematopoiesis and athero-thrombosis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider